Naphazoline (Clear, All)

Subscribe to Selected New Research on Naphazoline

133 relevant articles (5 outcomes, 8 trials/studies) found for this Drug

Description: An adrenergic vasoconstrictor agent used as a decongestant.

Also Known As:

Clear, All; All Clear; Idril; Privin; Albalon; Nafazair; Naphcon forte; Vasocon; AK-Con; Abbot Brand of Naphazoline Hydrochloride; Afazol Grin; Akorn Brand of Naphazoline Hydrochloride; Alcon Brand 1 of Naphazoline Hydrochloride; Alcon Brand 2 of Naphazoline Hydrochloride; Allergan Brand of Naphazoline Hydrochloride; Bausch & Lomb Brand 1 of Naphazoline Hydrochloride; Bausch & Lomb Brand 2 of Naphazoline Hydrochloride; Chauvin Brand of Naphazoline Hydrochloride; Ciba Vision Brand 1 of Naphazoline Hydrochloride; Ciba Vision Brand 2 of Naphazoline Hydrochloride; Clear Eyes; Colirio Alfa; Febena Brand of Naphazoline Hydrochloride; Grin Brand of Naphazoline Hydrochloride; Iquinosa Brand of Naphazoline Hydrochloride; Miraclar; Naphazoline Hydrochloride; Naphazoline Monohydrochloride; Naphazoline Nitrate; Naphcon; Novartis Brand 1 of Naphazoline Hydrochloride; Novartis Brand 2 of Naphazoline Hydrochloride; Optazine; Optima Brand of Naphazoline Hydrochloride; Privine; Proculin; Ross Brand of Naphazoline Hydrochloride; Siozwo; Stulln Brand of Naphazoline Hydrochloride; Tele-Stulln; VasoNit; Vasoclear; Vasocon Regular; Vasoconstrictor Pensa; Warner-Lambert Brand of Naphazoline Nitrate; Whitehall Brand of Naphazoline Hydrochloride; Winzer Brand of Naphazoline Hydrochloride; AK Con; AKCon; Alfa, Colirio; Eyes, Clear; Grin, Afazol; Hydrochloride, Naphazoline; Monohydrochloride, Naphazoline; Nitrate, Naphazoline; Pensa, Vasoconstrictor; Regular, Vasocon; Tele Stulln; TeleStulln; Warner Lambert Brand of Naphazoline Nitrate; forte, Naphcon; 1H-Imidazole, 4,5-dihydro-2-(1-naphthalenylmethyl)-

Relationship Network

Drug Context: Research Results

Heterocyclic Compounds: 23

1-Ring Heterocyclic Compounds

Twen Pantocaine-Privin

Experts

1.	Wenzel, S: 2 articles (07/2004 - 02/2003)
2.	Metternich, F U: 2 articles (07/2004 - 02/2003)
3.	Sagowski, C: 2 articles (07/2004 - 02/2003)
4.	Laux, G: 2 articles (07/2004 - 02/2003)
5.	Kehrl, W: 2 articles (07/2004 - 02/2003)
6.	Okuchi, Kazuo: 1 article (03/2008)
7.	Nishiguchi, Takashi: 1 article (03/2008)
8.	Nakamura, Tatsuya: 1 article (03/2008)
9.	Norimoto, Kazunobu: 1 article (03/2008)
10.	Konobu, Toshifumi: 1 article (03/2008)

Related Diseases

1.	Pruritus (Itching) 04/01/1990 - "The results of this study indicate that the combination of naphazoline and antazoline was more effective in inhibiting redness than naphazoline and more effective in inhibiting itching than antazoline" 08/01/1980 - "In two independent studies including 25 subjects each, naphazoline caused significant whitening (but did not prevent itching) in the histamine-induced red, itchy eye" 08/01/1980 - "The combination of naphazoline and antazoline produced significant whitening and inhibition of itching in all eyes challenged by histamine" 04/01/1990 - "Vasocon-A was found to significantly inhibit all five major signs and symptoms of allergic conjunctivitis: itching, redness, chemosis, lid swelling, and tearing, for more than 85% of the comparisons when compared over time with placebo, naphazoline alone, or antazoline alone" 08/01/1975 - "Evaluation of response at various times after instillation of medication for lacrimation, conjunctival inflammation, pruritis, photophobia and pain showed naphazoline hydrochloride, antazoline phosphate and the combination product superior to placebo" Order ALL the reference details at left...
2.	Intermittent Claudication 01/01/2003 - "This paper deals with an open no incomparable study of the efficacy of vasonit retard in the treatment of intermittent claudication in patients suffering from arterial pathology" 01/01/2003 - "Thus, talking into account the clinical evidence and the data supplied by instrumental diagnostic techniques, it is necessary to admit that vasonit retard is an effective drug for the treatment of patients suffering from intermittent claudication." 01/01/2003 - "Vasonit retard in the treatment of intermittent claudication in patients with obliterating diseases of the lower extremities]" Order ALL the reference details at left...
3.	Infection 05/01/1992 - "Our results show that (i) infection starts at the fetal stage and is maintained throughout adulthood, and (ii) this chronic infection of the thymus can be eliminated by transfer of virus-specific cytotoxic T lymphocytes (CTL) that infiltrate the thymus and clear all viral products from both medullary and cortical regions" 08/01/2006 - "It feels good to be told that I'm all clear": patients' accounts of retesting following genital chlamydial infection." 01/01/2004 - "For example, the pro-inflammatory response is quite limited, and with the exception of the type I interferons, it is not at all clear what innate responses are necessary to provide protection from acute infection" Order ALL the reference details at left...
4.	Mydriasis 04/01/1998 - "Mydriasis from inadvertent topical application of naphazoline hydrochloride (Opcon-A, Bausch & Lomb)" 03/01/2001 - "Topical unilateral application of naphazoline (7.5, 25 and 75 micro g; 25 micro l) elicited an ipsilateral dose-dependent mydriasis (2, 4 and 5.5 mm) that peaked at 2 hr with a duration of up to 5 hr. The IOP decreases induced by naphazoline were bilateral and dose-dependent (3, 6 and 10 mmHg); the response peaked at 1 hr and lasted for up to 5 hr. Pretreatment with efaroxan (250 micro g) elicited significantly greater antagonism of the ocular hypotensive response to naphazoline than did rauwolscine (250 micro g) suggesting an involvement of imidazoline (I(1)) receptors" Order ALL the reference details at left...
5.	Ocular Hypotension 03/01/2001 - "In addition to producing ocular hypotension, topical application of naphazoline (75 micro g; 25 micro l) caused significant reduction, from 2.8 to 1.5 micro l min(-1), in aqueous humor flow" Order ALL the reference details at left...

Related Drugs and Biologics

1.	Antazoline (Antazoline Phosphate)
2.	Yohimbine (Yocon)
3.	efaroxan
4.	Naphazoline (Clear, All)
5.	Histamine (Histamine Dihydrochloride)
6.	Pheniramine (Pheniramine Maleate)
7.	Oxymetazoline
8.	Dexamethasone (Maxidex)
9.	Proteins (Proteins, Gene)
10.	Pentoxifylline (Trental)

Related Therapies and Procedures

1.	First Aid (Aids, First)
2.	Cholecystectomy
3.	Laser In Situ Keratomileusis (LASIK)
4.	Heterologous Transplantation (Xenotransplantation)
5.	Tonsillectomy

Best Treatments:
Research Summary Report
on Pruritus

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 548 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>